APO Research, Inc.

APO RESEARCH · REPORT

Human Interleukin ELISA Kit

Selected research

Market Analysis & Forecast

Global Human Interleukin ELISA Kit Market Analysis and Forecast 2026-2032

Market perspective

The global Human Interleukin ELISA Kit market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Human Interleukin ELISA Kit is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Human Interleukin ELISA Kit is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Human Interleukin ELISA Kit is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Human Interleukin ELISA Kit is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global manufacturers of Human Interleukin ELISA Kit include Abcam, Mabtech AB, Aviva Systems Biology, G Biosciences, MD Bioproducts, OriGene Technologies, Eagle Bioscience, Novus Biologicals and Thermo Fisher Scientific, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Human Interleukin ELISA Kit, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Human Interleukin ELISA Kit, also provides the sales of main regions and countries. Of the upcoming market potential for Human Interleukin ELISA Kit, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Human Interleukin ELISA Kit sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Human Interleukin ELISA Kit market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Human Interleukin ELISA Kit sales, projected growth trends, production technology, application and end-user industry.

Human Interleukin ELISA Kit Segment by Company

Abcam

Mabtech AB

Aviva Systems Biology

G Biosciences

MD Bioproducts

OriGene Technologies

Eagle Bioscience

Novus Biologicals

Thermo Fisher Scientific

Enzo Life Sciences

BioLegend

DEMEDITEC Diagnostics

ScienCell Research Laboratories

Exreprotein

R&D Systems

Cell Sciences

AssayPro

BPS Bioscience

ACROBiosystems

Cayman Chemical

BosterBio

Bioassay Technology Laboratory

Kamiya Biomedical Company

Reddot Biotech

Krishgen Biosystems

RayBiotech

United States Biological

Sino Biological

CUSABIO Technology

Bioss

MyBioSource.com

BioVendor Laboratory Medicine

Abbexa

Fine Biotech

Biorbyt

Human Interleukin ELISA Kit Segment by Type

Sandwich ELISA

Competitive ELISA

Direct ELISA

Indirect ELISA

Human Interleukin ELISA Kit Segment by Application

Clinical Diagnosis

Drug Development

Human Interleukin ELISA Kit Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Human Interleukin ELISA Kit market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Human Interleukin ELISA Kit and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Human Interleukin ELISA Kit.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Sales (consumption), revenue of Human Interleukin ELISA Kit in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of Human Interleukin ELISA Kit manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Human Interleukin ELISA Kit sales, revenue, price, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 10: China type, by application, sales, and revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Human Interleukin ELISA Kit Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Sandwich ELISA Major Manufacturers Table 3. Competitive ELISA Major Manufacturers Table 4. Direct ELISA Major Manufacturers Table 5. Indirect ELISA Major Manufacturers Table 6. Global Human Interleukin ELISA Kit Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 7. Clinical Diagnosis Major Manufacturers Table 8. Drug Development Major Manufacturers Table 9. Human Interleukin ELISA Kit Industry Trends Table 10. Human Interleukin ELISA Kit Industry Drivers Table 11. Human Interleukin ELISA Kit Industry Opportunities and Challenges Table 12. Human Interleukin ELISA Kit Industry Restraints Table 13. Global Human Interleukin ELISA Kit Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 14. Global Human Interleukin ELISA Kit Revenue by Region (2021-2026) & (US$ Million) Table 15. Global Human Interleukin ELISA Kit Revenue by Region (2027-2032) & (US$ Million) Table 16. Global Human Interleukin ELISA Kit Revenue Market Share by Region (2021-2026) Table 17. Global Human Interleukin ELISA Kit Revenue Market Share by Region (2027-2032) Table 18. Global Human Interleukin ELISA Kit Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (k units) Table 19. Global Human Interleukin ELISA Kit Sales by Region (2021-2026) & (k units) Table 20. Global Human Interleukin ELISA Kit Sales by Region (2027-2032) & (k units) Table 21. Global Human Interleukin ELISA Kit Sales Market Share by Region (2021-2026) Table 22. Global Human Interleukin ELISA Kit Sales Market Share by Region (2027-2032) Table 23. Global Human Interleukin ELISA Kit Revenue by Manufacturers (US$ Million) & (2021-2026) Table 24. Global Human Interleukin ELISA Kit Revenue Market Share by Manufacturers (2021-2026) Table 25. Global Human Interleukin ELISA Kit Sales by Manufacturers (US$ Million) & (2021-2026) Table 26. Global Human Interleukin ELISA Kit Sales Market Share by Manufacturers (2021-2026) Table 27. Global Human Interleukin ELISA Kit Sales Price (USD/unit) of Manufacturers (2021-2026) Table 28. Global Human Interleukin ELISA Kit Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 29. Global Human Interleukin ELISA Kit Key Manufacturers Manufacturing Sites & Headquarters Table 30. Global Human Interleukin ELISA Kit Manufacturers, Product Type & Application Table 31. Global Human Interleukin ELISA Kit Manufacturers' Establishment Date Table 32. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 33. Global Human Interleukin ELISA Kit by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 34. Global Human Interleukin ELISA Kit Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 35. Global Human Interleukin ELISA Kit Revenue by Type (2021-2026) & (US$ Million) Table 36. Global Human Interleukin ELISA Kit Revenue by Type (2027-2032) & (US$ Million) Table 37. Global Human Interleukin ELISA Kit Revenue Market Share by Type (2021-2026) Table 38. Global Human Interleukin ELISA Kit Revenue Market Share by Type (2027-2032) Table 39. Global Human Interleukin ELISA Kit Sales by Type 2021 VS 2025 VS 2032 (k units) Table 40. Global Human Interleukin ELISA Kit Sales by Type (2021-2026) & (k units) Table 41. Global Human Interleukin ELISA Kit Sales by Type (2027-2032) & (k units) Table 42. Global Human Interleukin ELISA Kit Sales Market Share by Type (2021-2026) Table 43. Global Human Interleukin ELISA Kit Sales Market Share by Type (2027-2032) Table 44. Global Human Interleukin ELISA Kit Price by Type (2021-2026) & (USD/unit) Table 45. Global Human Interleukin ELISA Kit Price by Type (2027-2032) & (USD/unit) Table 46. Global Human Interleukin ELISA Kit Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 47. Global Human Interleukin ELISA Kit Revenue by Application (2021-2026) & (US$ Million) Table 48. Global Human Interleukin ELISA Kit Revenue by Application (2027-2032) & (US$ Million) Table 49. Global Human Interleukin ELISA Kit Revenue Market Share by Application (2021-2026) Table 50. Global Human Interleukin ELISA Kit Revenue Market Share by Application (2027-2032) Table 51. Global Human Interleukin ELISA Kit Sales by Application 2021 VS 2025 VS 2032 (k units) Table 52. Global Human Interleukin ELISA Kit Sales by Application (2021-2026) & (k units) Table 53. Global Human Interleukin ELISA Kit Sales by Application (2027-2032) & (k units) Table 54. Global Human Interleukin ELISA Kit Sales Market Share by Application (2021-2026) Table 55. Global Human Interleukin ELISA Kit Sales Market Share by Application (2027-2032) Table 56. Global Human Interleukin ELISA Kit Price by Application (2021-2026) & (USD/unit) Table 57. Global Human Interleukin ELISA Kit Price by Application (2027-2032) & (USD/unit) Table 58. Abcam Company Information Table 59. Abcam Business Overview Table 60. Abcam Human Interleukin ELISA Kit Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 61. Abcam Human Interleukin ELISA Kit Product Portfolio Table 62. Abcam Recent Development Table 63. Mabtech AB Company Information Table 64. Mabtech AB Business Overview Table 65. Mabtech AB Human Interleukin ELISA Kit Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 66. Mabtech AB Human Interleukin ELISA Kit Product Portfolio Table 67. Mabtech AB Recent Development Table 68. Aviva Systems Biology Company Information Table 69. Aviva Systems Biology Business Overview Table 70. Aviva Systems Biology Human Interleukin ELISA Kit Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 71. Aviva Systems Biology Human Interleukin ELISA Kit Product Portfolio Table 72. Aviva Systems Biology Recent Development Table 73. G Biosciences Company Information Table 74. G Biosciences Business Overview Table 75. G Biosciences Human Interleukin ELISA Kit Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 76. G Biosciences Human Interleukin ELISA Kit Product Portfolio Table 77. G Biosciences Recent Development Table 78. MD Bioproducts Company Information Table 79. MD Bioproducts Business Overview Table 80. MD Bioproducts Human Interleukin ELISA Kit Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 81. MD Bioproducts Human Interleukin ELISA Kit Product Portfolio Table 82. MD Bioproducts Recent Development Table 83. OriGene Technologies Company Information Table 84. OriGene Technologies Business Overview Table 85. OriGene Technologies Human Interleukin ELISA Kit Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 86. OriGene Technologies Human Interleukin ELISA Kit Product Portfolio Table 87. OriGene Technologies Recent Development Table 88. Eagle Bioscience Company Information Table 89. Eagle Bioscience Business Overview Table 90. Eagle Bioscience Human Interleukin ELISA Kit Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 91. Eagle Bioscience Human Interleukin ELISA Kit Product Portfolio Table 92. Eagle Bioscience Recent Development Table 93. Novus Biologicals Company Information Table 94. Novus Biologicals Business Overview Table 95. Novus Biologicals Human Interleukin ELISA Kit Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 96. Novus Biologicals Human Interleukin ELISA Kit Product Portfolio Table 97. Novus Biologicals Recent Development Table 98. Thermo Fisher Scientific Company Information Table 99. Thermo Fisher Scientific Business Overview Table 100. Thermo Fisher Scientific Human Interleukin ELISA Kit Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 101. Thermo Fisher Scientific Human Interleukin ELISA Kit Product Portfolio Table 102. Thermo Fisher Scientific Recent Development Table 103. Enzo Life Sciences Company Information Table 104. Enzo Life Sciences Business Overview Table 105. Enzo Life Sciences Human Interleukin ELISA Kit Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 106. Enzo Life Sciences Human Interleukin ELISA Kit Product Portfolio Table 107. Enzo Life Sciences Recent Development Table 108. BioLegend Company Information Table 109. BioLegend Business Overview Table 110. BioLegend Human Interleukin ELISA Kit Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 111. BioLegend Human Interleukin ELISA Kit Product Portfolio Table 112. BioLegend Recent Development Table 113. DEMEDITEC Diagnostics Company Information Table 114. DEMEDITEC Diagnostics Business Overview Table 115. DEMEDITEC Diagnostics Human Interleukin ELISA Kit Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 116. DEMEDITEC Diagnostics Human Interleukin ELISA Kit Product Portfolio Table 117. DEMEDITEC Diagnostics Recent Development Table 118. ScienCell Research Laboratories Company Information Table 119. ScienCell Research Laboratories Business Overview Table 120. ScienCell Research Laboratories Human Interleukin ELISA Kit Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 121. ScienCell Research Laboratories Human Interleukin ELISA Kit Product Portfolio Table 122. ScienCell Research Laboratories Recent Development Table 123. Exreprotein Company Information Table 124. Exreprotein Business Overview Table 125. Exreprotein Human Interleukin ELISA Kit Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 126. Exreprotein Human Interleukin ELISA Kit Product Portfolio Table 127. Exreprotein Recent Development Table 128. R&D Systems Company Information Table 129. R&D Systems Business Overview Table 130. R&D Systems Human Interleukin ELISA Kit Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 131. R&D Systems Human Interleukin ELISA Kit Product Portfolio Table 132. R&D Systems Recent Development Table 133. Cell Sciences Company Information Table 134. Cell Sciences Business Overview Table 135. Cell Sciences Human Interleukin ELISA Kit Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 136. Cell Sciences Human Interleukin ELISA Kit Product Portfolio Table 137. Cell Sciences Recent Development Table 138. AssayPro Company Information Table 139. AssayPro Business Overview Table 140. AssayPro Human Interleukin ELISA Kit Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 141. AssayPro Human Interleukin ELISA Kit Product Portfolio Table 142. AssayPro Recent Development Table 143. BPS Bioscience Company Information Table 144. BPS Bioscience Business Overview Table 145. BPS Bioscience Human Interleukin ELISA Kit Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 146. BPS Bioscience Human Interleukin ELISA Kit Product Portfolio Table 147. BPS Bioscience Recent Development Table 148. ACROBiosystems Company Information Table 149. ACROBiosystems Business Overview Table 150. ACROBiosystems Human Interleukin ELISA Kit Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 151. ACROBiosystems Human Interleukin ELISA Kit Product Portfolio Table 152. ACROBiosystems Recent Development Table 153. Cayman Chemical Company Information Table 154. Cayman Chemical Business Overview Table 155. Cayman Chemical Human Interleukin ELISA Kit Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 156. Cayman Chemical Human Interleukin ELISA Kit Product Portfolio Table 157. Cayman Chemical Recent Development Table 158. BosterBio Company Information Table 159. BosterBio Business Overview Table 160. BosterBio Human Interleukin ELISA Kit Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 161. BosterBio Human Interleukin ELISA Kit Product Portfolio Table 162. BosterBio Recent Development Table 163. Bioassay Technology Laboratory Company Information Table 164. Bioassay Technology Laboratory Business Overview Table 165. Bioassay Technology Laboratory Human Interleukin ELISA Kit Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 166. Bioassay Technology Laboratory Human Interleukin ELISA Kit Product Portfolio Table 167. Bioassay Technology Laboratory Recent Development Table 168. Kamiya Biomedical Company Company Information Table 169. Kamiya Biomedical Company Business Overview Table 170. Kamiya Biomedical Company Human Interleukin ELISA Kit Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 171. Kamiya Biomedical Company Human Interleukin ELISA Kit Product Portfolio Table 172. Kamiya Biomedical Company Recent Development Table 173. Reddot Biotech Company Information Table 174. Reddot Biotech Business Overview Table 175. Reddot Biotech Human Interleukin ELISA Kit Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 176. Reddot Biotech Human Interleukin ELISA Kit Product Portfolio Table 177. Reddot Biotech Recent Development Table 178. Krishgen Biosystems Company Information Table 179. Krishgen Biosystems Business Overview Table 180. Krishgen Biosystems Human Interleukin ELISA Kit Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 181. Krishgen Biosystems Human Interleukin ELISA Kit Product Portfolio Table 182. Krishgen Biosystems Recent Development Table 183. RayBiotech Company Information Table 184. RayBiotech Business Overview Table 185. RayBiotech Human Interleukin ELISA Kit Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 186. RayBiotech Human Interleukin ELISA Kit Product Portfolio Table 187. RayBiotech Recent Development Table 188. United States Biological Company Information Table 189. United States Biological Business Overview Table 190. United States Biological Human Interleukin ELISA Kit Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 191. United States Biological Human Interleukin ELISA Kit Product Portfolio Table 192. United States Biological Recent Development Table 193. Sino Biological Company Information Table 194. Sino Biological Business Overview Table 195. Sino Biological Human Interleukin ELISA Kit Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 196. Sino Biological Human Interleukin ELISA Kit Product Portfolio Table 197. Sino Biological Recent Development Table 198. CUSABIO Technology Company Information Table 199. CUSABIO Technology Business Overview Table 200. CUSABIO Technology Human Interleukin ELISA Kit Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 201. CUSABIO Technology Human Interleukin ELISA Kit Product Portfolio Table 202. CUSABIO Technology Recent Development Table 203. Bioss Company Information Table 204. Bioss Business Overview Table 205. Bioss Human Interleukin ELISA Kit Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 206. Bioss Human Interleukin ELISA Kit Product Portfolio Table 207. Bioss Recent Development Table 208. MyBioSource.com Company Information Table 209. MyBioSource.com Business Overview Table 210. MyBioSource.com Human Interleukin ELISA Kit Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 211. MyBioSource.com Human Interleukin ELISA Kit Product Portfolio Table 212. MyBioSource.com Recent Development Table 213. BioVendor Laboratory Medicine Company Information Table 214. BioVendor Laboratory Medicine Business Overview Table 215. BioVendor Laboratory Medicine Human Interleukin ELISA Kit Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 216. BioVendor Laboratory Medicine Human Interleukin ELISA Kit Product Portfolio Table 217. BioVendor Laboratory Medicine Recent Development Table 218. Abbexa Company Information Table 219. Abbexa Business Overview Table 220. Abbexa Human Interleukin ELISA Kit Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 221. Abbexa Human Interleukin ELISA Kit Product Portfolio Table 222. Abbexa Recent Development Table 223. Fine Biotech Company Information Table 224. Fine Biotech Business Overview Table 225. Fine Biotech Human Interleukin ELISA Kit Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 226. Fine Biotech Human Interleukin ELISA Kit Product Portfolio Table 227. Fine Biotech Recent Development Table 228. Biorbyt Company Information Table 229. Biorbyt Business Overview Table 230. Biorbyt Human Interleukin ELISA Kit Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 231. Biorbyt Human Interleukin ELISA Kit Product Portfolio Table 232. Biorbyt Recent Development Table 233. North America Human Interleukin ELISA Kit Revenue by Type (2021-2026) & (US$ Million) Table 234. North America Human Interleukin ELISA Kit Revenue by Type (2027-2032) & (US$ Million) Table 235. North America Human Interleukin ELISA Kit Sales by Type (2021-2026) & (k units) Table 236. North America Human Interleukin ELISA Kit Sales by Type (2027-2032) & (k units) Table 237. North America Human Interleukin ELISA Kit Sales Price by Type (2021-2026) & (USD/unit) Table 238. North America Human Interleukin ELISA Kit Sales Price by Type (2027-2032) & (USD/unit) Table 239. North America Human Interleukin ELISA Kit Revenue by Application (2021-2026) & (US$ Million) Table 240. North America Human Interleukin ELISA Kit Revenue by Application (2027-2032) & (US$ Million) Table 241. North America Human Interleukin ELISA Kit Sales by Application (2021-2026) & (k units) Table 242. North America Human Interleukin ELISA Kit Sales by Application (2027-2032) & (k units) Table 243. North America Human Interleukin ELISA Kit Sales Price by Application (2021-2026) & (USD/unit) Table 244. North America Human Interleukin ELISA Kit Sales Price by Application (2027-2032) & (USD/unit) Table 245. North America Human Interleukin ELISA Kit Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 246. North America Human Interleukin ELISA Kit Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 247. North America Human Interleukin ELISA Kit Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 248. North America Human Interleukin ELISA Kit Sales by Country (2021 VS 2025 VS 2032) & (k units) Table 249. North America Human Interleukin ELISA Kit Sales by Country (2021-2026) & (k units) Table 250. North America Human Interleukin ELISA Kit Sales by Country (2027-2032) & (k units) Table 251. North America Human Interleukin ELISA Kit Sales Price by Country (2021-2026) & (USD/unit) Table 252. North America Human Interleukin ELISA Kit Sales Price by Country (2027-2032) & (USD/unit) Table 253. United States Human Interleukin ELISA Kit Revenue (2021-2032) & (US$ Million) Table 254. Canada Human Interleukin ELISA Kit Revenue (2021-2032) & (US$ Million) Table 255. Mexico Human Interleukin ELISA Kit Revenue (2021-2032) & (US$ Million) Table 256. Europe Human Interleukin ELISA Kit Revenue by Type (2021-2026) & (US$ Million) Table 257. Europe Human Interleukin ELISA Kit Revenue by Type (2027-2032) & (US$ Million) Table 258. Europe Human Interleukin ELISA Kit Sales by Type (2021-2026) & (k units) Table 259. Europe Human Interleukin ELISA Kit Sales by Type (2027-2032) & (k units) Table 260. Europe Human Interleukin ELISA Kit Sales Price by Type (2021-2026) & (USD/unit) Table 261. Europe Human Interleukin ELISA Kit Sales Price by Type (2027-2032) & (USD/unit) Table 262. Europe Human Interleukin ELISA Kit Revenue by Application (2021-2026) & (US$ Million) Table 263. Europe Human Interleukin ELISA Kit Revenue by Application (2027-2032) & (US$ Million) Table 264. Europe Human Interleukin ELISA Kit Sales by Application (2021-2026) & (k units) Table 265. Europe Human Interleukin ELISA Kit Sales by Application (2027-2032) & (k units) Table 266. Europe Human Interleukin ELISA Kit Sales Price by Application (2021-2026) & (USD/unit) Table 267. Europe Human Interleukin ELISA Kit Sales Price by Application (2027-2032) & (USD/unit) Table 268. Europe Human Interleukin ELISA Kit Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 269. Europe Human Interleukin ELISA Kit Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 270. Europe Human Interleukin ELISA Kit Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 271. Europe Human Interleukin ELISA Kit Sales by Country (2021 VS 2025 VS 2032) & (k units) Table 272. Europe Human Interleukin ELISA Kit Sales by Country (2021-2026) & (k units) Table 273. Europe Human Interleukin ELISA Kit Sales by Country (2027-2032) & (k units) Table 274. Europe Human Interleukin ELISA Kit Sales Price by Country (2021-2026) & (USD/unit) Table 275. Europe Human Interleukin ELISA Kit Sales Price by Country (2027-2032) & (USD/unit) Table 276. Germany Human Interleukin ELISA Kit Revenue (2021-2032) & (US$ Million) Table 277. France Human Interleukin ELISA Kit Revenue (2021-2032) & (US$ Million) Table 278. U.K. Human Interleukin ELISA Kit Revenue (2021-2032) & (US$ Million) Table 279. Italy Human Interleukin ELISA Kit Revenue (2021-2032) & (US$ Million) Table 280. Russia Human Interleukin ELISA Kit Revenue (2021-2032) & (US$ Million) Table 281. Spain Human Interleukin ELISA Kit Revenue (2021-2032) & (US$ Million) Table 282. Netherlands Human Interleukin ELISA Kit Revenue (2021-2032) & (US$ Million) Table 283. Switzerland Human Interleukin ELISA Kit Revenue (2021-2032) & (US$ Million) Table 284. Sweden Human Interleukin ELISA Kit Revenue (2021-2032) & (US$ Million) Table 285. Poland Human Interleukin ELISA Kit Revenue (2021-2032) & (US$ Million) Table 286. China Human Interleukin ELISA Kit Revenue by Type (2021-2026) & (US$ Million) Table 287. China Human Interleukin ELISA Kit Revenue by Type (2027-2032) & (US$ Million) Table 288. China Human Interleukin ELISA Kit Sales by Type (2021-2026) & (k units) Table 289. China Human Interleukin ELISA Kit Sales by Type (2027-2032) & (k units) Table 290. China Human Interleukin ELISA Kit Sales Price by Type (2021-2026) & (USD/unit) Table 291. China Human Interleukin ELISA Kit Sales Price by Type (2027-2032) & (USD/unit) Table 292. China Human Interleukin ELISA Kit Revenue by Application (2021-2026) & (US$ Million) Table 293. China Human Interleukin ELISA Kit Revenue by Application (2027-2032) & (US$ Million) Table 294. China Human Interleukin ELISA Kit Sales by Application (2021-2026) & (k units) Table 295. China Human Interleukin ELISA Kit Sales by Application (2027-2032) & (k units) Table 296. China Human Interleukin ELISA Kit Sales Price by Application (2021-2026) & (USD/unit) Table 297. China Human Interleukin ELISA Kit Sales Price by Application (2027-2032) & (USD/unit) Table 298. Asia Human Interleukin ELISA Kit Revenue by Type (2021-2026) & (US$ Million) Table 299. Asia Human Interleukin ELISA Kit Revenue by Type (2027-2032) & (US$ Million) Table 300. Asia Human Interleukin ELISA Kit Sales by Type (2021-2026) & (k units) Table 301. Asia Human Interleukin ELISA Kit Sales by Type (2027-2032) & (k units) Table 302. Asia Human Interleukin ELISA Kit Sales Price by Type (2021-2026) & (USD/unit) Table 303. Asia Human Interleukin ELISA Kit Sales Price by Type (2027-2032) & (USD/unit) Table 304. Asia Human Interleukin ELISA Kit Revenue by Application (2021-2026) & (US$ Million) Table 305. Asia Human Interleukin ELISA Kit Revenue by Application (2027-2032) & (US$ Million) Table 306. Asia Human Interleukin ELISA Kit Sales by Application (2021-2026) & (k units) Table 307. Asia Human Interleukin ELISA Kit Sales by Application (2027-2032) & (k units) Table 308. Asia Human Interleukin ELISA Kit Sales Price by Application (2021-2026) & (USD/unit) Table 309. Asia Human Interleukin ELISA Kit Sales Price by Application (2027-2032) & (USD/unit) Table 310. Asia Human Interleukin ELISA Kit Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 311. Asia Human Interleukin ELISA Kit Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 312. Asia Human Interleukin ELISA Kit Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 313. Asia Human Interleukin ELISA Kit Sales by Country (2021 VS 2025 VS 2032) & (k units) Table 314. Asia Human Interleukin ELISA Kit Sales by Country (2021-2026) & (k units) Table 315. Asia Human Interleukin ELISA Kit Sales by Country (2027-2032) & (k units) Table 316. Asia Human Interleukin ELISA Kit Sales Price by Country (2021-2026) & (USD/unit) Table 317. Asia Human Interleukin ELISA Kit Sales Price by Country (2027-2032) & (USD/unit) Table 318. Japan Human Interleukin ELISA Kit Revenue (2021-2032) & (US$ Million) Table 319. South Korea Human Interleukin ELISA Kit Revenue (2021-2032) & (US$ Million) Table 320. India Human Interleukin ELISA Kit Revenue (2021-2032) & (US$ Million) Table 321. Australia Human Interleukin ELISA Kit Revenue (2021-2032) & (US$ Million) Table 322. Taiwan Human Interleukin ELISA Kit Revenue (2021-2032) & (US$ Million) Table 323. Southeast Asia Human Interleukin ELISA Kit Revenue (2021-2032) & (US$ Million) Table 324. SAMEA Human Interleukin ELISA Kit Revenue by Type (2021-2026) & (US$ Million) Table 325. SAMEA Human Interleukin ELISA Kit Revenue by Type (2027-2032) & (US$ Million) Table 326. SAMEA Human Interleukin ELISA Kit Sales by Type (2021-2026) & (k units) Table 327. SAMEA Human Interleukin ELISA Kit Sales by Type (2027-2032) & (k units) Table 328. SAMEA Human Interleukin ELISA Kit Sales Price by Type (2021-2026) & (USD/unit) Table 329. SAMEA Human Interleukin ELISA Kit Sales Price by Type (2027-2032) & (USD/unit) Table 330. SAMEA Human Interleukin ELISA Kit Revenue by Application (2021-2026) & (US$ Million) Table 331. SAMEA Human Interleukin ELISA Kit Revenue by Application (2027-2032) & (US$ Million) Table 332. SAMEA Human Interleukin ELISA Kit Sales by Application (2021-2026) & (k units) Table 333. SAMEA Human Interleukin ELISA Kit Sales by Application (2027-2032) & (k units) Table 334. SAMEA Human Interleukin ELISA Kit Sales Price by Application (2021-2026) & (USD/unit) Table 335. SAMEA Human Interleukin ELISA Kit Sales Price by Application (2027-2032) & (USD/unit) Table 336. SAMEA Human Interleukin ELISA Kit Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 337. SAMEA Human Interleukin ELISA Kit Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 338. SAMEA Human Interleukin ELISA Kit Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 339. SAMEA Human Interleukin ELISA Kit Sales by Country (2021 VS 2025 VS 2032) & (k units) Table 340. SAMEA Human Interleukin ELISA Kit Sales by Country (2021-2026) & (k units) Table 341. SAMEA Human Interleukin ELISA Kit Sales by Country (2027-2032) & (k units) Table 342. SAMEA Human Interleukin ELISA Kit Sales Price by Country (2021-2026) & (USD/unit) Table 343. SAMEA Human Interleukin ELISA Kit Sales Price by Country (2027-2032) & (USD/unit) Table 344. Brazil Human Interleukin ELISA Kit Revenue (2021-2032) & (US$ Million) Table 345. Argentina Human Interleukin ELISA Kit Revenue (2021-2032) & (US$ Million) Table 346. Chile Human Interleukin ELISA Kit Revenue (2021-2032) & (US$ Million) Table 347. Colombia Human Interleukin ELISA Kit Revenue (2021-2032) & (US$ Million) Table 348. Peru Human Interleukin ELISA Kit Revenue (2021-2032) & (US$ Million) Table 349. Saudi Arabia Human Interleukin ELISA Kit Revenue (2021-2032) & (US$ Million) Table 350. Israel Human Interleukin ELISA Kit Revenue (2021-2032) & (US$ Million) Table 351. UAE Human Interleukin ELISA Kit Revenue (2021-2032) & (US$ Million) Table 352. Turkey Human Interleukin ELISA Kit Revenue (2021-2032) & (US$ Million) Table 353. Iran Human Interleukin ELISA Kit Revenue (2021-2032) & (US$ Million) Table 354. Egypt Human Interleukin ELISA Kit Revenue (2021-2032) & (US$ Million) Table 355. Key Raw Materials Table 356. Raw Materials Key Suppliers Table 357. Human Interleukin ELISA Kit Distributors List Table 358. Human Interleukin ELISA Kit Customers List Table 359. Research Programs/Design for This Report Table 360. Authors List of This Report Table 361. Secondary Sources Table 362. Primary Sources List of Figures Figure 1. Human Interleukin ELISA Kit Image Figure 2. Global Human Interleukin ELISA Kit Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Human Interleukin ELISA Kit Market Size Share 2021 VS 2025 VS 2032 Figure 4. Sandwich ELISA Image Figure 5. Competitive ELISA Image Figure 6. Direct ELISA Image Figure 7. Indirect ELISA Image Figure 8. Global Human Interleukin ELISA Kit Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 9. Global Human Interleukin ELISA Kit Market Size Share 2021 VS 2025 VS 2032 Figure 10. Clinical Diagnosis Image Figure 11. Drug Development Image Figure 12. Global Human Interleukin ELISA Kit Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 13. Global Human Interleukin ELISA Kit Revenue (2021-2032) & (US$ Million) Figure 14. Global Human Interleukin ELISA Kit Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 15. Global Human Interleukin ELISA Kit Revenue Market Share by Region: 2025 Versus 2032 Figure 16. Global Human Interleukin ELISA Kit Revenue Market Share by Region (2021-2032) Figure 17. Global Human Interleukin ELISA Kit Sales (2021-2032) & (k units) Figure 18. Global Human Interleukin ELISA Kit Sales by Region: 2021 VS 2025 VS 2032 (k units) Figure 19. Global Human Interleukin ELISA Kit Sales Market Share by Region (2021-2032) Figure 20. US & Canada & Mexico Human Interleukin ELISA Kit Sales YoY (2021-2032) & (k units) Figure 21. Europe Human Interleukin ELISA Kit Sales YoY (2021-2032) & (k units) Figure 22. China Human Interleukin ELISA Kit Sales YoY (2021-2032) & (k units) Figure 23. Asia (Excluding China) Human Interleukin ELISA Kit Sales YoY (2021-2032) & (k units) Figure 24. South America, Middle East and Africa Human Interleukin ELISA Kit Sales YoY (2021-2032) & (k units) Figure 25. Global Human Interleukin ELISA Kit Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 26. Global Human Interleukin ELISA Kit Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 27. Manufact

Scope & coverage.

Types
  • Sandwich ELISA
  • Competitive ELISA
  • Direct ELISA
  • Indirect ELISA
Applications
  • Clinical Diagnosis
  • Drug Development
Companies covered
  • Abcam
  • Mabtech AB
  • Aviva Systems Biology
  • G Biosciences
  • MD Bioproducts
  • OriGene Technologies
  • Eagle Bioscience
  • Novus Biologicals
  • Thermo Fisher Scientific
  • Enzo Life Sciences
  • BioLegend
  • DEMEDITEC Diagnostics
  • ScienCell Research Laboratories
  • Exreprotein
  • R&D Systems
  • Cell Sciences
  • AssayPro
  • BPS Bioscience
  • ACROBiosystems
  • Cayman Chemical
  • BosterBio
  • Bioassay Technology Laboratory
  • Kamiya Biomedical Company
  • Reddot Biotech
  • Krishgen Biosystems
  • RayBiotech
  • United States Biological
  • Sino Biological
  • CUSABIO Technology
  • Bioss
  • MyBioSource.com
  • BioVendor Laboratory Medicine
  • Abbexa
  • Fine Biotech
  • Biorbyt

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Human Interleukin ELISA Kit Market by Type
  3. 1.2.1 Global Human Interleukin ELISA Kit Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Sandwich ELISA
  5. 1.2.3 Competitive ELISA
  6. 1.2.4 Direct ELISA
  7. 1.2.5 Indirect ELISA
  8. 1.3 Human Interleukin ELISA Kit Market by Application
  9. 1.3.1 Global Human Interleukin ELISA Kit Market Size by Application, 2021 VS 2025 VS 2032
  10. 1.3.2 Clinical Diagnosis
  11. 1.3.3 Drug Development
  12. 1.4 Assumptions and Limitations
  13. 1.5 Study Goals and Objectives
2 Human Interleukin ELISA Kit Market Dynamics
  1. 2.1 Human Interleukin ELISA Kit Industry Trends
  2. 2.2 Human Interleukin ELISA Kit Industry Drivers
  3. 2.3 Human Interleukin ELISA Kit Industry Opportunities and Challenges
  4. 2.4 Human Interleukin ELISA Kit Industry Restraints
3 Global Market Growth Prospects
  1. 3.1 Global Human Interleukin ELISA Kit Revenue Estimates and Forecasts (2021-2032)
  2. 3.2 Global Human Interleukin ELISA Kit Revenue by Region
  3. 3.2.1 Global Human Interleukin ELISA Kit Revenue by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Human Interleukin ELISA Kit Revenue by Region (2021-2026)
  5. 3.2.3 Global Human Interleukin ELISA Kit Revenue by Region (2027-2032)
  6. 3.2.4 Global Human Interleukin ELISA Kit Revenue Market Share by Region (2021-2032)
  7. 3.3 Global Human Interleukin ELISA Kit Sales Estimates and Forecasts 2021-2032
  8. 3.4 Global Human Interleukin ELISA Kit Sales by Region
  9. 3.4.1 Global Human Interleukin ELISA Kit Sales by Region: 2021 VS 2025 VS 2032
  10. 3.4.2 Global Human Interleukin ELISA Kit Sales by Region (2021-2026)
  11. 3.4.3 Global Human Interleukin ELISA Kit Sales by Region (2027-2032)
  12. 3.4.4 Global Human Interleukin ELISA Kit Sales Market Share by Region (2021-2032)
  13. 3.5 US & Canada & Mexico
  14. 3.6 Europe
  15. 3.7 China
  16. 3.8 Asia (Excluding China)
  17. 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
  1. 4.1 Global Human Interleukin ELISA Kit Revenue by Manufacturers
  2. 4.1.1 Global Human Interleukin ELISA Kit Revenue by Manufacturers (2021-2026)
  3. 4.1.2 Global Human Interleukin ELISA Kit Revenue Market Share by Manufacturers (2021-2026)
  4. 4.1.3 Global Human Interleukin ELISA Kit Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Human Interleukin ELISA Kit Sales by Manufacturers
  6. 4.2.1 Global Human Interleukin ELISA Kit Sales by Manufacturers (2021-2026)
  7. 4.2.2 Global Human Interleukin ELISA Kit Sales Market Share by Manufacturers (2021-2026)
  8. 4.2.3 Global Human Interleukin ELISA Kit Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 4.3 Global Human Interleukin ELISA Kit Sales Price by Manufacturers (2021-2026)
  10. 4.4 Global Human Interleukin ELISA Kit Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 4.5 Global Human Interleukin ELISA Kit Key Manufacturers Manufacturing Sites & Headquarters
  12. 4.6 Global Human Interleukin ELISA Kit Manufacturers, Product Type & Application
  13. 4.7 Global Human Interleukin ELISA Kit Manufacturers' Establishment Date
  14. 4.8 Market Competitive Analysis
  15. 4.8.1 Global Human Interleukin ELISA Kit Market CR5 and HHI
  16. 4.8.2 2025 Human Interleukin ELISA Kit Tier 1, Tier 2, and Tier 3
5 Human Interleukin ELISA Kit Market by Type
  1. 5.1 Global Human Interleukin ELISA Kit Revenue by Type
  2. 5.1.1 Global Human Interleukin ELISA Kit Revenue by Type (2021 VS 2025 VS 2032)
  3. 5.1.2 Global Human Interleukin ELISA Kit Revenue by Type (2021-2032) & (US$ Million)
  4. 5.1.3 Global Human Interleukin ELISA Kit Revenue Market Share by Type (2021-2032)
  5. 5.2 Global Human Interleukin ELISA Kit Sales by Type
  6. 5.2.1 Global Human Interleukin ELISA Kit Sales by Type (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Human Interleukin ELISA Kit Sales by Type (2021-2032) & (k units)
  8. 5.2.3 Global Human Interleukin ELISA Kit Sales Market Share by Type (2021-2032)
  9. 5.3 Global Human Interleukin ELISA Kit Price by Type
6 Human Interleukin ELISA Kit Market by Application
  1. 6.1 Global Human Interleukin ELISA Kit Revenue by Application
  2. 6.1.1 Global Human Interleukin ELISA Kit Revenue by Application (2021 VS 2025 VS 2032)
  3. 6.1.2 Global Human Interleukin ELISA Kit Revenue by Application (2021-2032) & (US$ Million)
  4. 6.1.3 Global Human Interleukin ELISA Kit Revenue Market Share by Application (2021-2032)
  5. 6.2 Global Human Interleukin ELISA Kit Sales by Application
  6. 6.2.1 Global Human Interleukin ELISA Kit Sales by Application (2021 VS 2025 VS 2032)
  7. 6.2.2 Global Human Interleukin ELISA Kit Sales by Application (2021-2032) & (k units)
  8. 6.2.3 Global Human Interleukin ELISA Kit Sales Market Share by Application (2021-2032)
  9. 6.3 Global Human Interleukin ELISA Kit Price by Application
7 Company Profiles
  1. 7.1 Abcam
  2. 7.1.1 Abcam Company Information
  3. 7.1.2 Abcam Business Overview
  4. 7.1.3 Abcam Human Interleukin ELISA Kit Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 7.1.4 Abcam Human Interleukin ELISA Kit Product Portfolio
  6. 7.1.5 Abcam Recent Developments
  7. 7.2 Mabtech AB
  8. 7.2.1 Mabtech AB Company Information
  9. 7.2.2 Mabtech AB Business Overview
  10. 7.2.3 Mabtech AB Human Interleukin ELISA Kit Sales, Revenue, Price and Gross Margin (2021-2026)
  11. 7.2.4 Mabtech AB Human Interleukin ELISA Kit Product Portfolio
  12. 7.2.5 Mabtech AB Recent Developments
  13. 7.3 Aviva Systems Biology
  14. 7.3.1 Aviva Systems Biology Company Information
  15. 7.3.2 Aviva Systems Biology Business Overview
  16. 7.3.3 Aviva Systems Biology Human Interleukin ELISA Kit Sales, Revenue, Price and Gross Margin (2021-2026)
  17. 7.3.4 Aviva Systems Biology Human Interleukin ELISA Kit Product Portfolio
  18. 7.3.5 Aviva Systems Biology Recent Developments
  19. 7.4 G Biosciences
  20. 7.4.1 G Biosciences Company Information
  21. 7.4.2 G Biosciences Business Overview
  22. 7.4.3 G Biosciences Human Interleukin ELISA Kit Sales, Revenue, Price and Gross Margin (2021-2026)
  23. 7.4.4 G Biosciences Human Interleukin ELISA Kit Product Portfolio
  24. 7.4.5 G Biosciences Recent Developments
  25. 7.5 MD Bioproducts
  26. 7.5.1 MD Bioproducts Company Information
  27. 7.5.2 MD Bioproducts Business Overview
  28. 7.5.3 MD Bioproducts Human Interleukin ELISA Kit Sales, Revenue, Price and Gross Margin (2021-2026)
  29. 7.5.4 MD Bioproducts Human Interleukin ELISA Kit Product Portfolio
  30. 7.5.5 MD Bioproducts Recent Developments
  31. 7.6 OriGene Technologies
  32. 7.6.1 OriGene Technologies Company Information
  33. 7.6.2 OriGene Technologies Business Overview
  34. 7.6.3 OriGene Technologies Human Interleukin ELISA Kit Sales, Revenue, Price and Gross Margin (2021-2026)
  35. 7.6.4 OriGene Technologies Human Interleukin ELISA Kit Product Portfolio
  36. 7.6.5 OriGene Technologies Recent Developments
  37. 7.7 Eagle Bioscience
  38. 7.7.1 Eagle Bioscience Company Information
  39. 7.7.2 Eagle Bioscience Business Overview
  40. 7.7.3 Eagle Bioscience Human Interleukin ELISA Kit Sales, Revenue, Price and Gross Margin (2021-2026)
  41. 7.7.4 Eagle Bioscience Human Interleukin ELISA Kit Product Portfolio
  42. 7.7.5 Eagle Bioscience Recent Developments
  43. 7.8 Novus Biologicals
  44. 7.8.1 Novus Biologicals Company Information
  45. 7.8.2 Novus Biologicals Business Overview
  46. 7.8.3 Novus Biologicals Human Interleukin ELISA Kit Sales, Revenue, Price and Gross Margin (2021-2026)
  47. 7.8.4 Novus Biologicals Human Interleukin ELISA Kit Product Portfolio
  48. 7.8.5 Novus Biologicals Recent Developments
  49. 7.9 Thermo Fisher Scientific
  50. 7.9.1 Thermo Fisher Scientific Company Information
  51. 7.9.2 Thermo Fisher Scientific Business Overview
  52. 7.9.3 Thermo Fisher Scientific Human Interleukin ELISA Kit Sales, Revenue, Price and Gross Margin (2021-2026)
  53. 7.9.4 Thermo Fisher Scientific Human Interleukin ELISA Kit Product Portfolio
  54. 7.9.5 Thermo Fisher Scientific Recent Developments
  55. 7.10 Enzo Life Sciences
  56. 7.10.1 Enzo Life Sciences Company Information
  57. 7.10.2 Enzo Life Sciences Business Overview
  58. 7.10.3 Enzo Life Sciences Human Interleukin ELISA Kit Sales, Revenue, Price and Gross Margin (2021-2026)
  59. 7.10.4 Enzo Life Sciences Human Interleukin ELISA Kit Product Portfolio
  60. 7.10.5 Enzo Life Sciences Recent Developments
  61. 7.11 BioLegend
  62. 7.11.1 BioLegend Company Information
  63. 7.11.2 BioLegend Business Overview
  64. 7.11.3 BioLegend Human Interleukin ELISA Kit Sales, Revenue, Price and Gross Margin (2021-2026)
  65. 7.11.4 BioLegend Human Interleukin ELISA Kit Product Portfolio
  66. 7.11.5 BioLegend Recent Developments
  67. 7.12 DEMEDITEC Diagnostics
  68. 7.12.1 DEMEDITEC Diagnostics Company Information
  69. 7.12.2 DEMEDITEC Diagnostics Business Overview
  70. 7.12.3 DEMEDITEC Diagnostics Human Interleukin ELISA Kit Sales, Revenue, Price and Gross Margin (2021-2026)
  71. 7.12.4 DEMEDITEC Diagnostics Human Interleukin ELISA Kit Product Portfolio
  72. 7.12.5 DEMEDITEC Diagnostics Recent Developments
  73. 7.13 ScienCell Research Laboratories
  74. 7.13.1 ScienCell Research Laboratories Company Information
  75. 7.13.2 ScienCell Research Laboratories Business Overview
  76. 7.13.3 ScienCell Research Laboratories Human Interleukin ELISA Kit Sales, Revenue, Price and Gross Margin (2021-2026)
  77. 7.13.4 ScienCell Research Laboratories Human Interleukin ELISA Kit Product Portfolio
  78. 7.13.5 ScienCell Research Laboratories Recent Developments
  79. 7.14 Exreprotein
  80. 7.14.1 Exreprotein Company Information
  81. 7.14.2 Exreprotein Business Overview
  82. 7.14.3 Exreprotein Human Interleukin ELISA Kit Sales, Revenue, Price and Gross Margin (2021-2026)
  83. 7.14.4 Exreprotein Human Interleukin ELISA Kit Product Portfolio
  84. 7.14.5 Exreprotein Recent Developments
  85. 7.15 R&D Systems
  86. 7.15.1 R&D Systems Company Information
  87. 7.15.2 R&D Systems Business Overview
  88. 7.15.3 R&D Systems Human Interleukin ELISA Kit Sales, Revenue, Price and Gross Margin (2021-2026)
  89. 7.15.4 R&D Systems Human Interleukin ELISA Kit Product Portfolio
  90. 7.15.5 R&D Systems Recent Developments
  91. 7.16 Cell Sciences
  92. 7.16.1 Cell Sciences Company Information
  93. 7.16.2 Cell Sciences Business Overview
  94. 7.16.3 Cell Sciences Human Interleukin ELISA Kit Sales, Revenue, Price and Gross Margin (2021-2026)
  95. 7.16.4 Cell Sciences Human Interleukin ELISA Kit Product Portfolio
  96. 7.16.5 Cell Sciences Recent Developments
  97. 7.17 AssayPro
  98. 7.17.1 AssayPro Company Information
  99. 7.17.2 AssayPro Business Overview
  100. 7.17.3 AssayPro Human Interleukin ELISA Kit Sales, Revenue, Price and Gross Margin (2021-2026)
  101. 7.17.4 AssayPro Human Interleukin ELISA Kit Product Portfolio
  102. 7.17.5 AssayPro Recent Developments
  103. 7.18 BPS Bioscience
  104. 7.18.1 BPS Bioscience Company Information
  105. 7.18.2 BPS Bioscience Business Overview
  106. 7.18.3 BPS Bioscience Human Interleukin ELISA Kit Sales, Revenue, Price and Gross Margin (2021-2026)
  107. 7.18.4 BPS Bioscience Human Interleukin ELISA Kit Product Portfolio
  108. 7.18.5 BPS Bioscience Recent Developments
  109. 7.19 ACROBiosystems
  110. 7.19.1 ACROBiosystems Company Information
  111. 7.19.2 ACROBiosystems Business Overview
  112. 7.19.3 ACROBiosystems Human Interleukin ELISA Kit Sales, Revenue, Price and Gross Margin (2021-2026)
  113. 7.19.4 ACROBiosystems Human Interleukin ELISA Kit Product Portfolio
  114. 7.19.5 ACROBiosystems Recent Developments
  115. 7.20 Cayman Chemical
  116. 7.20.1 Cayman Chemical Company Information
  117. 7.20.2 Cayman Chemical Business Overview
  118. 7.20.3 Cayman Chemical Human Interleukin ELISA Kit Sales, Revenue, Price and Gross Margin (2021-2026)
  119. 7.20.4 Cayman Chemical Human Interleukin ELISA Kit Product Portfolio
  120. 7.20.5 Cayman Chemical Recent Developments
  121. 7.21 BosterBio
  122. 7.21.1 BosterBio Company Information
  123. 7.21.2 BosterBio Business Overview
  124. 7.21.3 BosterBio Human Interleukin ELISA Kit Sales, Revenue, Price and Gross Margin (2021-2026)
  125. 7.21.4 BosterBio Human Interleukin ELISA Kit Product Portfolio
  126. 7.21.5 BosterBio Recent Developments
  127. 7.22 Bioassay Technology Laboratory
  128. 7.22.1 Bioassay Technology Laboratory Company Information
  129. 7.22.2 Bioassay Technology Laboratory Business Overview
  130. 7.22.3 Bioassay Technology Laboratory Human Interleukin ELISA Kit Sales, Revenue, Price and Gross Margin (2021-2026)
  131. 7.22.4 Bioassay Technology Laboratory Human Interleukin ELISA Kit Product Portfolio
  132. 7.22.5 Bioassay Technology Laboratory Recent Developments
  133. 7.23 Kamiya Biomedical Company
  134. 7.23.1 Kamiya Biomedical Company Company Information
  135. 7.23.2 Kamiya Biomedical Company Business Overview
  136. 7.23.3 Kamiya Biomedical Company Human Interleukin ELISA Kit Sales, Revenue, Price and Gross Margin (2021-2026)
  137. 7.23.4 Kamiya Biomedical Company Human Interleukin ELISA Kit Product Portfolio
  138. 7.23.5 Kamiya Biomedical Company Recent Developments
  139. 7.24 Reddot Biotech
  140. 7.24.1 Reddot Biotech Company Information
  141. 7.24.2 Reddot Biotech Business Overview
  142. 7.24.3 Reddot Biotech Human Interleukin ELISA Kit Sales, Revenue, Price and Gross Margin (2021-2026)
  143. 7.24.4 Reddot Biotech Human Interleukin ELISA Kit Product Portfolio
  144. 7.24.5 Reddot Biotech Recent Developments
  145. 7.25 Krishgen Biosystems
  146. 7.25.1 Krishgen Biosystems Company Information
  147. 7.25.2 Krishgen Biosystems Business Overview
  148. 7.25.3 Krishgen Biosystems Human Interleukin ELISA Kit Sales, Revenue, Price and Gross Margin (2021-2026)
  149. 7.25.4 Krishgen Biosystems Human Interleukin ELISA Kit Product Portfolio
  150. 7.25.5 Krishgen Biosystems Recent Developments
  151. 7.26 RayBiotech
  152. 7.26.1 RayBiotech Company Information
  153. 7.26.2 RayBiotech Business Overview
  154. 7.26.3 RayBiotech Human Interleukin ELISA Kit Sales, Revenue, Price and Gross Margin (2021-2026)
  155. 7.26.4 RayBiotech Human Interleukin ELISA Kit Product Portfolio
  156. 7.26.5 RayBiotech Recent Developments
  157. 7.27 United States Biological
  158. 7.27.1 United States Biological Company Information
  159. 7.27.2 United States Biological Business Overview
  160. 7.27.3 United States Biological Human Interleukin ELISA Kit Sales, Revenue, Price and Gross Margin (2021-2026)
  161. 7.27.4 United States Biological Human Interleukin ELISA Kit Product Portfolio
  162. 7.27.5 United States Biological Recent Developments
  163. 7.28 Sino Biological
  164. 7.28.1 Sino Biological Company Information
  165. 7.28.2 Sino Biological Business Overview
  166. 7.28.3 Sino Biological Human Interleukin ELISA Kit Sales, Revenue, Price and Gross Margin (2021-2026)
  167. 7.28.4 Sino Biological Human Interleukin ELISA Kit Product Portfolio
  168. 7.28.5 Sino Biological Recent Developments
  169. 7.29 CUSABIO Technology
  170. 7.29.1 CUSABIO Technology Company Information
  171. 7.29.2 CUSABIO Technology Business Overview
  172. 7.29.3 CUSABIO Technology Human Interleukin ELISA Kit Sales, Revenue, Price and Gross Margin (2021-2026)
  173. 7.29.4 CUSABIO Technology Human Interleukin ELISA Kit Product Portfolio
  174. 7.29.5 CUSABIO Technology Recent Developments
  175. 7.30 Bioss
  176. 7.30.1 Bioss Company Information
  177. 7.30.2 Bioss Business Overview
  178. 7.30.3 Bioss Human Interleukin ELISA Kit Sales, Revenue, Price and Gross Margin (2021-2026)
  179. 7.30.4 Bioss Human Interleukin ELISA Kit Product Portfolio
  180. 7.30.5 Bioss Recent Developments
  181. 7.31 MyBioSource.com
  182. 7.31.1 MyBioSource.com Company Information
  183. 7.31.2 MyBioSource.com Business Overview
  184. 7.31.3 MyBioSource.com Human Interleukin ELISA Kit Sales, Revenue, Price and Gross Margin (2021-2026)
  185. 7.31.4 MyBioSource.com Human Interleukin ELISA Kit Product Portfolio
  186. 7.31.5 MyBioSource.com Recent Developments
  187. 7.32 BioVendor Laboratory Medicine
  188. 7.32.1 BioVendor Laboratory Medicine Company Information
  189. 7.32.2 BioVendor Laboratory Medicine Business Overview
  190. 7.32.3 BioVendor Laboratory Medicine Human Interleukin ELISA Kit Sales, Revenue, Price and Gross Margin (2021-2026)
  191. 7.32.4 BioVendor Laboratory Medicine Human Interleukin ELISA Kit Product Portfolio
  192. 7.32.5 BioVendor Laboratory Medicine Recent Developments
  193. 7.33 Abbexa
  194. 7.33.1 Abbexa Company Information
  195. 7.33.2 Abbexa Business Overview
  196. 7.33.3 Abbexa Human Interleukin ELISA Kit Sales, Revenue, Price and Gross Margin (2021-2026)
  197. 7.33.4 Abbexa Human Interleukin ELISA Kit Product Portfolio
  198. 7.33.5 Abbexa Recent Developments
  199. 7.34 Fine Biotech
  200. 7.34.1 Fine Biotech Company Information
  201. 7.34.2 Fine Biotech Business Overview
  202. 7.34.3 Fine Biotech Human Interleukin ELISA Kit Sales, Revenue, Price and Gross Margin (2021-2026)
  203. 7.34.4 Fine Biotech Human Interleukin ELISA Kit Product Portfolio
  204. 7.34.5 Fine Biotech Recent Developments
  205. 7.35 Biorbyt
  206. 7.35.1 Biorbyt Company Information
  207. 7.35.2 Biorbyt Business Overview
  208. 7.35.3 Biorbyt Human Interleukin ELISA Kit Sales, Revenue, Price and Gross Margin (2021-2026)
  209. 7.35.4 Biorbyt Human Interleukin ELISA Kit Product Portfolio
  210. 7.35.5 Biorbyt Recent Developments
8 North America
  1. 8.1 North America Human Interleukin ELISA Kit Market Size by Type
  2. 8.1.1 North America Human Interleukin ELISA Kit Revenue by Type (2021-2032)
  3. 8.1.2 North America Human Interleukin ELISA Kit Sales by Type (2021-2032)
  4. 8.1.3 North America Human Interleukin ELISA Kit Price by Type (2021-2032)
  5. 8.2 North America Human Interleukin ELISA Kit Market Size by Application
  6. 8.2.1 North America Human Interleukin ELISA Kit Revenue by Application (2021-2032)
  7. 8.2.2 North America Human Interleukin ELISA Kit Sales by Application (2021-2032)
  8. 8.2.3 North America Human Interleukin ELISA Kit Price by Application (2021-2032)
  9. 8.3 North America Human Interleukin ELISA Kit Market Size by Country
  10. 8.3.1 North America Human Interleukin ELISA Kit Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 8.3.2 North America Human Interleukin ELISA Kit Sales by Country (2021 VS 2025 VS 2032)
  12. 8.3.3 North America Human Interleukin ELISA Kit Price by Country (2021-2032)
  13. 8.3.4 United States
  14. 8.3.5 Canada
  15. 8.3.6 Mexico
9 Europe
  1. 9.1 Europe Human Interleukin ELISA Kit Market Size by Type
  2. 9.1.1 Europe Human Interleukin ELISA Kit Revenue by Type (2021-2032)
  3. 9.1.2 Europe Human Interleukin ELISA Kit Sales by Type (2021-2032)
  4. 9.1.3 Europe Human Interleukin ELISA Kit Price by Type (2021-2032)
  5. 9.2 Europe Human Interleukin ELISA Kit Market Size by Application
  6. 9.2.1 Europe Human Interleukin ELISA Kit Revenue by Application (2021-2032)
  7. 9.2.2 Europe Human Interleukin ELISA Kit Sales by Application (2021-2032)
  8. 9.2.3 Europe Human Interleukin ELISA Kit Price by Application (2021-2032)
  9. 9.3 Europe Human Interleukin ELISA Kit Market Size by Country
  10. 9.3.1 Europe Human Interleukin ELISA Kit Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 Europe Human Interleukin ELISA Kit Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 Europe Human Interleukin ELISA Kit Price by Country (2021-2032)
  13. 9.3.4 Germany
  14. 9.3.5 France
  15. 9.3.6 U.K.
  16. 9.3.7 Italy
  17. 9.3.8 Russia
  18. 9.3.9 Spain
  19. 9.3.10 Netherlands
10 China
  1. 10.1 China Human Interleukin ELISA Kit Market Size by Type
  2. 10.1.1 China Human Interleukin ELISA Kit Revenue by Type (2021-2032)
  3. 10.1.2 China Human Interleukin ELISA Kit Sales by Type (2021-2032)
  4. 10.1.3 China Human Interleukin ELISA Kit Price by Type (2021-2032)
  5. 10.2 China Human Interleukin ELISA Kit Market Size by Application
  6. 10.2.1 China Human Interleukin ELISA Kit Revenue by Application (2021-2032)
  7. 10.2.2 China Human Interleukin ELISA Kit Sales by Application (2021-2032)
  8. 10.2.3 China Human Interleukin ELISA Kit Price by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Human Interleukin ELISA Kit Market Size by Type
  2. 11.1.1 Asia Human Interleukin ELISA Kit Revenue by Type (2021-2032)
  3. 11.1.2 Asia Human Interleukin ELISA Kit Sales by Type (2021-2032)
  4. 11.1.3 Asia Human Interleukin ELISA Kit Price by Type (2021-2032)
  5. 11.2 Asia Human Interleukin ELISA Kit Market Size by Application
  6. 11.2.1 Asia Human Interleukin ELISA Kit Revenue by Application (2021-2032)
  7. 11.2.2 Asia Human Interleukin ELISA Kit Sales by Application (2021-2032)
  8. 11.2.3 Asia Human Interleukin ELISA Kit Price by Application (2021-2032)
  9. 11.3 Asia Human Interleukin ELISA Kit Market Size by Country
  10. 11.3.1 Asia Human Interleukin ELISA Kit Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 11.3.2 Asia Human Interleukin ELISA Kit Sales by Country (2021 VS 2025 VS 2032)
  12. 11.3.3 Asia Human Interleukin ELISA Kit Price by Country (2021-2032)
  13. 11.3.4 Japan
  14. 11.3.5 South Korea
  15. 11.3.6 India
  16. 11.3.7 Australia
  17. 11.3.8 Taiwan
  18. 11.3.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Human Interleukin ELISA Kit Market Size by Type
  2. 12.1.1 SAMEA Human Interleukin ELISA Kit Revenue by Type (2021-2032)
  3. 12.1.2 SAMEA Human Interleukin ELISA Kit Sales by Type (2021-2032)
  4. 12.1.3 SAMEA Human Interleukin ELISA Kit Price by Type (2021-2032)
  5. 12.2 SAMEA Human Interleukin ELISA Kit Market Size by Application
  6. 12.2.1 SAMEA Human Interleukin ELISA Kit Revenue by Application (2021-2032)
  7. 12.2.2 SAMEA Human Interleukin ELISA Kit Sales by Application (2021-2032)
  8. 12.2.3 SAMEA Human Interleukin ELISA Kit Price by Application (2021-2032)
  9. 12.3 SAMEA Human Interleukin ELISA Kit Market Size by Country
  10. 12.3.1 SAMEA Human Interleukin ELISA Kit Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 SAMEA Human Interleukin ELISA Kit Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 SAMEA Human Interleukin ELISA Kit Price by Country (2021-2032)
  13. 12.3.4 Brazil
  14. 12.3.5 Argentina
  15. 12.3.6 Chile
  16. 12.3.7 Colombia
  17. 12.3.8 Peru
  18. 12.3.9 Saudi Arabia
  19. 12.3.10 Israel
  20. 12.3.11 UAE
  21. 12.3.12 Turkey
  22. 12.3.13 Iran
  23. 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
  1. 13.1 Human Interleukin ELISA Kit Value Chain Analysis
  2. 13.1.1 Human Interleukin ELISA Kit Key Raw Materials
  3. 13.1.2 Raw Materials Key Suppliers
  4. 13.1.3 Manufacturing Cost Structure
  5. 13.1.4 Human Interleukin ELISA Kit Production Mode & Process
  6. 13.2 Human Interleukin ELISA Kit Sales Channels Analysis
  7. 13.2.1 Direct Comparison with Distribution Share
  8. 13.2.2 Human Interleukin ELISA Kit Distributors
  9. 13.2.3 Human Interleukin ELISA Kit Customers
14 Concluding Insights
    15 Appendix
    1. 15.1 Reasons for Doing This Study
    2. 15.2 Research Methodology
    3. 15.3 Research Process
    4. 15.4 Authors List of This Report
    5. 15.5 Data Source
    6. 15.5.1 Secondary Sources
    7. 15.5.2 Primary Sources
    8. 15.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.